The Placebo Effect — Reading

Passage

A The word placebo entered medicine as an insult. Derived from the Latin for 'I shall please', it described a remedy given to satisfy a demanding patient rather than to treat them, and eighteenth-century dictionaries defined it with open contempt. Its transformation into a research instrument came later, when it became clear that a substance with no active ingredient was the only fair comparison for one that claimed to have an effect. The modern randomised controlled trial, in which neither patient nor doctor knows who received which, is built on that insight. B What complicates the picture is that the comparison group frequently improves. Patients given an inert tablet report less pain, reduced nausea and better sleep, and the improvement can be substantial. For decades this was taken as evidence that belief heals. The interpretation was too quick. Much of what looks like a placebo response is not a response to anything: illnesses fluctuate and often improve regardless, patients enrol when symptoms are at their worst, and people report more favourably to a researcher who has been kind to them. Careful analyses comparing placebo groups with groups receiving no treatment at all find the genuine effect considerably smaller than the raw numbers imply. C Smaller, however, is not zero, and the residue is real. Placebo analgesia has been shown to involve the release of the body's own opioids, and can be blocked by naloxone, a drug that reverses opioid effects — which is difficult to explain if nothing physiological is happening. Brain imaging shows activity in regions associated with pain modulation. In Parkinson's disease, placebo administration triggers measurable dopamine release. These are mechanisms, not impressions. D The effect is also strikingly sensitive to presentation in ways that make no pharmacological sense. Injections outperform tablets. Larger tablets outperform smaller ones, and two outperform one. Colour matters, and matters differently in different countries. Price matters: an identical inert tablet described as expensive relieves more pain than one described as cheap. Whatever is being manipulated, it is expectation rather than chemistry. E A finding that ought to be impossible has held up repeatedly. In open-label trials, patients told explicitly that they are receiving an inert pill with no active ingredient still improve, in conditions including irritable bowel syndrome and chronic back pain. This undermines the assumption that deception is necessary and suggests something in the ritual of treatment — the consultation, the attention, the act of taking something at a fixed time — carries effect independently of belief in the substance. F The mirror image is better documented than commonly realised. Nocebo effects, in which negative expectation produces symptoms, are why patients warned of a side effect report it more often than those who are not, and why the same list of possible harms increases the chance of experiencing them. This creates a genuine dilemma for clinicians, since informed consent requires disclosing risks that disclosure itself makes more likely. G What follows for practice is modest and often overstated. Placebos do not shrink tumours or clear infections; they act on symptoms that are themselves partly generated centrally, principally pain, nausea and fatigue. The defensible conclusion is not that belief substitutes for medicine, but that the context in which treatment is delivered is an active component of it — and one that is routinely discarded when consultations are shortened. H The ethics of using this knowledge deliberately in clinical practice remain contested, and the debate turns on a genuine dilemma rather than mere squeamishness. Prescribing an inert pill while telling a patient it is medication is a straightforward deception and is now widely regarded as unacceptable in most healthcare systems, regardless of any benefit it might produce. What has proven more interesting, and considerably less ethically fraught, is research into so-called open-label placebos: pills that patients are explicitly and honestly told contain no active ingredient, prescribed alongside a clear explanation of the placebo effect itself. Counter-intuitively, several controlled trials — in conditions including irritable bowel syndrome, chronic lower back pain, and cancer-related fatigue — have found that open-label placebos still produce measurable symptom improvement compared with no treatment at all, even though patients know exactly what they are taking. This suggests the effect does not depend on deception in the way earlier researchers assumed, but on the ritual of treatment and the expectation it sets in motion, which persists even under conditions of full disclosure. If the finding holds up under further replication, it offers something rare in medicine: a way to harness a real, measurable effect without lying to a single patient to obtain it.

বাংলা অনুবাদ জমা দেওয়ার পর দেখা যাবে — আগে ইংরেজিতে বোঝার চেষ্টা করুন।